Possible association of a cholecystokinin promotor polymorphism (CCK(- 36CT)) with panic disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 81, Issue 3, 1998, Pages 228-234

  Wang, Zhewu ^a   Valdes, John ^a   Noyes, Russell ^a   Zoega, Tomas ^b   Crowe, Raymond R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

CCK; Mutation; Panic disorder

Indexed keywords

CHOLECYSTOKININ;

ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; PANIC; PRIORITY JOURNAL; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; CHOLECYSTOKININ; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; HUMANS; ICELAND; IOWA; LINKAGE (GENETICS); MALE; MIDDLE AGED; PANIC DISORDER; PEDIGREE; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 0032496286     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S     Document Type: Article

References (29)

1. American Psychiatric Association (1980): "Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III)." Washington, DC: American Psychiatric Association, pp. 230-232.
2. American Psychiatric Association (1987): "Diagnostic and Statistical Manual of Mental Disorders, Third Edition-Revised (DSM-III-R)." Washington, DC: American Psychiatric Association, pp. 235-239.
3. American Psychiatric Association (1994): "Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)." Washington, DC: American Psychiatric Association, pp. 397-403.
4. Berkson J (1946): Limitations of the application of fourfold table analysis to hospital data. Biometrics Bull 2:47-53.
5. Bradwejn J, Koszycki D (1994): Imipramine antagonizes the panicogenic effects of CCK-4 in panic disorder patients. Am J Psychiatry 151:261-263.
6. Bradwejn J, Koszycki D, Shirqui C (1991): Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder: Clinical and behavioral findings. Arch Gen Psychiatry 48:603-610.
7. Charney DS, Woods SW, Goodman WK, Heninger GR (1987): Neurobiological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144:1030-1036.
8. Crawley JN, Corwin RL (1994): Biological actions of cholecystokinin. Peptides 15:731-755.
9. Crowe RR, Noyes R, Pauls DL, Slymen D (1983): A family study of panic disorder. Arch Gen Psychiatry 40:1065-1069.
10. Crowe RR, Noyes R Jr, Wilson AF, Elston RC, Ward LJ (1987): A linkage study of panic disorder. Arch Gen Psychiatry 44:933-937.
11. deMontigny C (1989): Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers: preliminary findings. Arch Gen Psychiatry 46:511-517.
12. Di Nardo PA, Moras K, Barlow DH, Rapee RM, Brown TA (1993): Reliability of the DSM-III-R anxiety disorder categories using the Anxiety Disorders Interview Schedule-Revised (ADIS-R). Arch Gen Psychiatry 46:511-517.
13. Eaton WW, Kessler RC, Wittchen HU, Magee WJ (1994): Panic and panic disorder in the United States. Am J Psychiatry 151:413-420.
14. 2 and hyperventilation in patients with panic disorder. Am J Psychiatry 151:547-553.
15. Greenberg DA (1993): Linkage analysis of "necessary" disease loci versus "susceptibility" loci. Am J Hum Genet 52:135-143.
16. Haun RS, Dixon JE (1990): A transcriptional enhancer essential for the expression of the rat cholecystokinin gene contains a sequence identical to the -296 element of the human c-fos gene. J Biol Chem 265:15455-63.
17. Kadonaga JT, Jones KA, Tjian R (1986): Promotor-specific activation of RNA polymerase II transcription by Sp 1. TIBS 11:20-23.
18. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1993): Panic disorder in women: A population-based twin study. Psychol Med 23:397-406.
19. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994): Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
20. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996): Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58:1347-1363.
21. Lathrop GM, Lalouel JM (1984): Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 36:460-465.
22. Lydiard RB, Ballenger JC, Laria MT, Fossey MD, Beinfeld MC (1992): CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry 149:691-693.
23. Nielsen FC, Pedersen K, Hansen TVO, Rourke IJ, Rehfeld JF (1996): Transcriptional regulation of the human cholecystokinin gene: Composite action of upstream stimulatory factor, Sp1, and members of the CREB/ATF-AP-1 family of transcription factors. DNA Cell Biol 15:53-63.
24. Pitts FN, McClure JN (1967): Lactate metabolism in anxiety neurosis. N Engl J Med 227:1329-1339.
25. Risch N (1988): A new statistical test for linkage heterogeneity. Am J Hum Genet 42:353-364.
26. Schmidt SM, Zoega T, Crowe RR (1993): Excluding linkage between panic disorder and the gamma-aminobutyric acid betal receptor locus in five Icelandic pedigrees. Acta Psychiatr Scand 88:225-228.
27. Sheehan DV, Sheehan KE, Minichiello WE (1981): Age of onset of phobic disorders: A reevaluation. Compr Psychiatry 22:544-553.
28. Shiang R, Lidral AC, Ardinger HH, Buetow KH, Romitti PA, Munger RG, Murray JC (1993): Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft papate only (CPO). Am J Hum Genet 53:836-843.
29. Spielman RS, McGinnis RE, Ewens WJ (1993): Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.